United Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:UTHR Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
30 Dec 24	SellUS$90,720	Nilda Mesa	Individual	255	US$355.77
18 Dec 24	SellUS$4,195,296	Louis Sullivan	Individual	11,209	US$382.25
11 Nov 24	SellUS$721,840	Judy Olian	Individual	1,750	US$412.48
08 Nov 24	SellUS$92,350	Nilda Mesa	Individual	224	US$412.28
01 Nov 24	SellUS$192,080	Christopher Causey	Individual	510	US$376.63
03 Sep 24	SellUS$405,492	James Edgemond	Individual	1,119	US$362.37
26 Aug 24	SellUS$393,831	James Edgemond	Individual	1,133	US$347.60
19 Aug 24	SellUS$382,321	James Edgemond	Individual	1,162	US$329.02
25 Jun 24	SellUS$84,742	Nilda Mesa	Individual	266	US$318.58
17 Jun 24	SellUS$502,225	Judy Olian	Individual	1,700	US$295.43

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of UTHR?
Owner Type	Number of Shares	Ownership Percentage
State or Government	49,162	0.105%
Individual Insiders	786,877	1.69%
Hedge Funds	2,675,000	5.74%
Institutions	43,107,618	92.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 66.6% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12.1%	BlackRock, Inc.	5,444,560	US$1.7b	1.64%	0.03%
9.88%	The Vanguard Group, Inc.	4,457,135	US$1.4b	0.34%	0.02%
5.93%	Avoro Capital Advisors LLC	2,675,000	US$842.2m	-3.09%	13.23%
4.95%	State Street Global Advisors, Inc.	2,230,708	US$702.3m	1.4%	0.02%
4.67%	Renaissance Technologies LLC	2,106,992	US$663.4m	0.84%	0.94%
4.49%	Wellington Management Group LLP	2,026,416	US$638.0m	-17.8%	0.1%
2.71%	Geode Capital Management, LLC	1,223,993	US$385.4m	7.53%	0.02%
2.5%	FMR LLC	1,127,910	US$355.1m	-22.2%	0.02%
2.01%	AQR Capital Management, LLC	906,606	US$285.4m	-5.74%	0.28%
2%	LSV Asset Management	902,323	US$284.1m	-0.7%	0.6%
1.48%	Martine Rothblatt	666,422	US$209.8m	3.4%	no data
1.38%	Dimensional Fund Advisors LP	624,711	US$196.7m	0.67%	0.03%
1.22%	Pacer Advisors, Inc.	548,092	US$172.6m	-8.29%	0.43%
1.15%	AssetMark, Inc.	518,450	US$163.2m	20.8%	0.42%
1.09%	Fuller & Thaler Asset Management, Inc.	491,127	US$154.6m	-7.84%	0.59%
1.06%	Caisse de dépôt et placement du Québec	477,757	US$150.4m	22.5%	0.14%
1.05%	Northern Trust Global Investments	471,365	US$148.4m	-3.58%	0.02%
1.01%	AllianceBernstein L.P.	454,983	US$143.2m	-35.8%	0.04%
0.95%	Norges Bank Investment Management	430,122	US$135.4m	0%	0.01%
0.88%	Arrowstreet Capital, Limited Partnership	398,230	US$125.4m	-26.6%	0.09%
0.87%	BNY Asset Management	391,176	US$123.2m	-0.12%	0.02%
0.87%	UBS Asset Management AG	390,979	US$123.1m	19.4%	0.01%
0.83%	Invesco Capital Management LLC	376,165	US$118.4m	189%	0.04%
0.78%	Charles Schwab Investment Management, Inc.	350,858	US$110.5m	-5.31%	0.02%
0.78%	Amundi Asset Management SAS	350,262	US$110.3m	198%	0.02%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/28 12:17
End of Day Share Price	2025/05/28 00:00
Earnings	2025/03/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

United Therapeutics Corporation is covered by 33 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jasper Hellweg	Argus Research Company
James Birchenough	Barclays
Derek Taller	Benchmark Company